ResearcherKeio UniversityNo recent work listed
Shigeru B. H. Ko
Matched on ORCID iD 0000-0003-1913-6357; OpenAlex author ID A5101584052. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2011: 2 papers · 2012: 1 paper · 2013: 1 paper
Papers 4
- Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma. Co-author DOI 10.3389/fphys.2013.00269↗
- Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis. Co-author DOI 10.1155/2012/510397↗
- How fast can pancreatic cancer grow? A case of pancreatic carcinoma developed within 5 months after a negative examination to the advanced stage with multiple … Co-author DOI 10.1097/mpa.0b013e3181fe4031↗
- Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318214efce↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hidemi Goto · 3 shared papers, 2011–2012 · strength 0.11
- Paper How fast can pancreatic cancer grow? A case of pancreatic carcinoma developed within 5 months after a negative examinat… DOI 10.1097/mpa.0b013e3181fe4031↗
- Paper Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer. DOI 10.1097/mpa.0b013e318214efce↗
- Paper Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination fr… DOI 10.1155/2012/510397↗
- Nobumasa Mizuno · 3 shared papers, 2011–2013 · strength 0.09
- Paper Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma. DOI 10.3389/fphys.2013.00269↗
- Paper Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer. DOI 10.1097/mpa.0b013e318214efce↗
- Paper Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination fr… DOI 10.1155/2012/510397↗
- Kenji Yamao · 2 shared papers, 2012–2013 · strength 0.06
- Susumu Hijioka · 1 shared paper, 2013 · strength 0.04
- Kazuo Hara · 1 shared paper, 2013 · strength 0.04
- Hiroshi Imaoka · 1 shared paper, 2013 · strength 0.04
- Yasushi Yatabe · 1 shared paper, 2013 · strength 0.04
- Naohiko Anzai · 1 shared paper, 2011 · strength 0.03
- Takeo KAWAHARA · 1 shared paper, 2012 · strength 0.03
- Kiyoshi Yanagisawa · 1 shared paper, 2012 · strength 0.03
- Masato Nagino · 1 shared paper, 2012 · strength 0.03
- Yukihiro Yokoyama · 1 shared paper, 2012 · strength 0.03
- Keitaro Matsuo · 1 shared paper, 2012 · strength 0.03
- Takashi Takahashi · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.